Replimune Group, Inc. (REPL)
NASDAQ: REPL · IEX Real-Time Price · USD
9.89
-0.17 (-1.69%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $607.40 million as of July 22, 2024. Its market cap has decreased by -50.25% in one year.
Market Cap
607.40M
Enterprise Value
260.90M
1-Year Change
-50.25%
Ranking
Category
Stock Price
$9.89
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.50M to $607.40M, an increase of 29.92%. That is a compound annual growth rate of 4.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 607.40M | 21.99% |
| Dec 29, 2023 | 497.90M | -63.20% |
| Dec 30, 2022 | 1.35B | 6.46% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | 1.75B | 281.78% |
| Dec 31, 2019 | 459.30M | 45.58% |
| Dec 31, 2018 | 315.50M | -32.51% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 624.97M |
| KalVista Pharmaceuticals | 621.80M |
| Corbus Pharmaceuticals Holdings | 619.83M |
| REGENXBIO | 619.64M |
| Astria Therapeutics | 615.03M |
| Celcuity | 606.55M |
| ProKidney | 602.24M |
| Avid Bioservices | 600.84M |